USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT ECZEMA

The invention relates to the use of a strain of probiotic lactic acid bacteria, Lactobacillus rhamnosus HN001 in the manufacture of compositions for the treatment or prevention of eczema. Compositions for use in the invention may be in the form of pharmaceutical compositions, infant formulas, follow-on formulas, growing-up formulas, maternal formulas, maternal supplements, dietetic products or foods. The compositions may be formulated for administration to a mother of a foetal subject or breastfeeding neonatal, infant or child subject when administering to the mother of the subject, or for administration to a neonatal, infant, child, juvenile or adult subject. FIG.2.